You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The role of the hepatitis c pharmacist in managing complex drug-drug interactions
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-122
- By: TORKINGTON, Adele (NORTH WEST ID UNIT @ NORTH MANCHESTER GENERAL HOSPITAL, Mrs)
- Co-author(s): Adele Marie Torkington
Sarah Cripps
Karen Lee
Anthony Pratt
Paul Selby
Katherine Davidson
Susan Spollen
Joyce Mahungu
Helen Morgan
Alison Boyle
Tina Vaghijiani
Fiona Marra
Anja St.clair-jones
Paul Gilvarry
Sandeep Whitehead - Abstract:
Background
Directly active antivirals (DAA’s) are highly effective to cure Hepatitis C (HCV). However HCV patients have co-morbidities which complicate the most cost effective treatment of HCV as the DAA’s have many drug-drug interactions (DDIs) It is recommended that co-medicines are assessed for DDI before and during treatment. Clinical.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026